Korean startup Illimis Therapeutics raises $42 M to accelerate CNS and immune disease drug development

South Korea-based startup Illimis Therapeutics has announced the closing of 58 billion KRW ($42 million) Series B financ...

July 15, 2025 | Tuesday | News
Waters and BD unite in $17.5B deal to lead life sciences and diagnostics

    Strong strategic fit that increases presence in multiple high-growth adjacencies and offers ...

July 14, 2025 | Monday | News
Australia designs new ultrasound imaging device to map drug delivery into brain

A new device combining ultrasound and advanced imaging to provide crucial information for the safe delivery of drugs int...

July 14, 2025 | Monday | News
Australia injects nearly $100 M in funding for emerging biomedical and medical technology solutions

The Albanese Government has awarded nearly $100 million in funding to three organisations for emerging Australian biomed...

July 11, 2025 | Friday | News
Univercells teams up with Repligen for real-time bioprocess monitoring

 Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing soluti...

July 9, 2025 | Wednesday | News
Japan's JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M

Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...

July 10, 2025 | Thursday | News
Chugai and Gero ink $250 M deal to develop new therapies for age-related diseases

Japan's Chugai Pharmaceutical and Gero, a Singapore-based biotechnology company, have entered into a joint research...

July 9, 2025 | Wednesday | News
Abu Dhabi plans to advance gene therapies for children with Spinal Muscular Atrophy Type 1

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...

July 7, 2025 | Monday | News
BeauEver secures New Zealand's support to accelerate global skincare expansion

At the 2025 China–New Zealand Trade Innovation Summit, New Zealand Prime Minister, Christopher Luxon, witnessed th...

July 4, 2025 | Friday | News
China's Brii Biosciences announces new agreement to address global antimicrobial resistance threats

Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across disea...

July 4, 2025 | Friday | News
AN Venture Partners announces one of the largest Japan focused biotech funds to date

AN Venture Partners (ANV), a global biotech venture capital firm, has announced the final close of its first fund, AN Ve...

July 3, 2025 | Thursday | News
Swiss-Singapore partnership to develop therapies for autoimmune diseases

RDP Pharma AG, a Swiss biotechnology company focused on next-generation protein degradation therapeutics, and the Experi...

July 3, 2025 | Thursday | News
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge

Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...

July 2, 2025 | Wednesday | Opinion
“The burden on medical and long-term care systems due to ageing is expected to intensify in Japan”

What major initiatives are lined up for Asahi's healthcare business in 2025 and beyond? Are you planning any major inves...

July 1, 2025 | Tuesday | Opinion
“APAC is dynamic and rapidly evolving, with tremendous growth in R&D and attractive market conditions”

What are the current developments taking place at CTMC, and what are your major plans for the next five years?  CT...

July 1, 2025 | Tuesday | Opinion
Taiwan’s biotech gathers momentum

Biomedicine is a key focus under Taiwan’s ‘5+2’ Innovative Industries Plan, with the government aiming...

July 1, 2025 | Tuesday | Analysis
Korea's Chungnam National University inks MoU with global mass spectrometry leader Sciex

Sciex, a global leader in life science analytical technologies, has signed a strategic Memorandum of Understanding (MoU)...

July 1, 2025 | Tuesday | News
Taiwanese startup HanchorBio signs $200 M deal to expand immuno-oncology reach

HanchorBio Inc., a Taiwan-based biotechnology startup developing innovative immunotherapies for oncology and autoimmune ...

July 1, 2025 | Tuesday | News